Hear from the Kirby Institute's presenters at this year's Conference on Retroviruses and Opportunistic Infections, CROI 2024. Our speakers will present key insights directly from the conference, offering a firsthand look at their research in infectious diseases.
Dr Joanne Carson will explore the elimination of HCV among people with HIV. The CEASE study assessed the impact of rapid scale up of direct acting antiviral therapy among people with HIV-HCV coinfection.
Associate Professor Lucette Cysique will present on the highlights from CROI 2024 NeuroHIV studies.
Dr Nick Medland will present findings from a study that uses five years of prescription and dispensing data to examine HIV acquisition in people who have received Australian government subsidised PrEP.
 |
Dr Joanne Carson |
 |
Associate Professor Lucette Cysique Lucette Cysique is a neuropsychologist with longstanding research and clinical experience in the impact of infectious diseases (i.e., HCV, HIV, |
 |
Dr Nick Medland Nick Medland is a sexual health and HIV physician, immediate past president of ASHM and chairs the Australian STI management guidelines. He has been at the Kirby Institute since 2018 and his area of research is the population control of HIV and sexually transmitted infection through clinical interventions, including HIV treatment as prevention and pre-exposure prophylaxis and STI testing and treatment. He has more than 25 years clinical experience, including in the community setting. For six years he worked in senior roles in US Government funded HIV programs in Vietnam |
Opinions expressed by individuals at this event are solely of those of the individual/s and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.